Cost Effectiveness and Resource Allocation

SJR Rank #7,052H-index: 48SJR: 0.789Best quartile: Q2Open AccessAPC: US$2,790Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Health PolicyQ2

Areas: Medicine

Most published research topics

Health Systems, Economic Evaluations, Quality of LifeHealthcare Systems and ReformsGlobal Maternal and Child HealthGlobal Health Care IssuesHealthcare Policy and ManagementEconomic and Financial Impacts of CancerPharmaceutical Economics and PolicyEconomic and Environmental ValuationPrimary Care and Health OutcomesEfficiency Analysis Using DEA

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs065130195260

Documents per Year

20222025020406080

Detailed Information

ISSN

1478-7547

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.97

References per Document

40.12

Coverage

2003-2026

Scope

Cost Effectiveness and Resource Allocation considers manuscripts on all aspects of cost-effectiveness analysis, including conceptual or methodological work, economic evaluations, and policy analysis related to resource allocation at a national or international level. Cost Effectiveness and Resource Allocation is aimed at health economists, health services researchers, and policy-makers with an interest in enhancing the flow and transfer of knowledge relating to efficiency in the health sector. Manuscripts are encouraged from researchers based in low- and middle-income countries, with a view to increasing the international economic evidence base for health. The journal particularly solicits manuscripts on the costs, effectiveness, or cost-effectiveness of health interventions, based on primary empirical research/data collection or via a modelling approach. A health intervention is defined broadly as any action whose primary intent is to improve health - promotive, preventive, curative and rehabilitative actions at the clinical or population level. As well as manuscripts reporting cost or cost-effectiveness data, the journal also considers contributions that report or discuss methodological aspects of economic evaluation - such as disease modelling, cost estimation, or uncertainty - and policy-related issues such as the interplay between efficiency and other decision-making criteria.

Metrics from SCImago Journal Rank 2025. View on SCImago